BCAL Diagnostics Limited BCAL Diagnostics Limited

BCAL Diagnostics Limited

BDX

Rank in Stocks #27360
BCAL Diagnostics Limited is a biotechnology firm focused on creating an... BCAL Diagnostics Limited is a biotechnology firm focused on creating an advanced, non-surgical laboratory blood test for the identification of breast cancer. Its flagship product, the BCAL test, is a lipid biomarker-based blood assay designed for potential use in breast cancer prevention strategies, early screening, and ongoing patient monitoring. This in vitro diagnostic (IVD) technology functions by detecting a unique pattern of lipid biomarkers, which are isolated from extracellular vesicles present in a patient's plasma or blood, thereby enabling the diagnosis of breast cancer cells. Established in 2010, the company's main operations are based in Sydney, Australia.
Share Price
$0.04067041
Last synced: 2026-11-16
Market Cap
$14.99M
Change (1 day)
-0.39%
Change (1 year)
-28.04%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
EPS for BCAL Diagnostics Limited (BDX)
EPS as of June 2026 TTM: $-0.01
According to BCAL Diagnostics Limited's latest financial reports, its current EPS (TTM) is $-0.01. At the end of 2025 the company had an EPS of $-0.01, an increase over its 2024 EPS of $-0.02.
EPS history for BCAL Diagnostics Limited from 2018 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.01 36.00%
2025 $-0.01 -24.14%
2024 $-0.02 8.75%
2023 $-0.02 40.35%
2022 $-0.01 115.09%
2021 $-0.01 140.91%
2020 0.00 57.14%
2019 0.00 -12.50%
2018 0.00 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$18.99 -139,732.35%
US
$6.12 -45,100.00%
US
$1.38 -10,217.65%
CN
$14.83 -109,144.12%
US
$5.09 -37,526.47%
US

Questions about BCAL Diagnostics Limited's earnings per share (EPS)

What is BCAL Diagnostics Limited's earnings per share (EPS)?

BCAL Diagnostics Limited's earnings per share (EPS) over the last twelve months is $-0.01, as of Jun 2026.

What was BCAL Diagnostics Limited's earnings per share (EPS) in 2025?

In 2025, BCAL Diagnostics Limited's earnings per share (EPS) was $-0.01, compared with $-0.02 in 2024.

How has BCAL Diagnostics Limited's earnings per share (EPS) changed since 2020?

From 2020 to 2025, BCAL Diagnostics Limited's earnings per share (EPS) was highest in 2020 (0.00) and lowest in 2024 ($-0.02).

How does BCAL Diagnostics Limited's earnings per share (EPS) compare with similar companies?

BCAL Diagnostics Limited's earnings per share (EPS) ($-0.01) is lower than that of all 5 similar companies listed above. The highest among them is Thermo Fisher Scientific Inc., with $18.99.